In particular, PD-1 and CTLA-4-related cellular markers suggest a significant role for immunoregulatory pathways in the context of EBV and CLL (Supplementary Materials, Table S14). This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.